Optic atrophy
Optic atrophy is not a single disease. It is the final outcome of various lesions of the optic nerve and damage to its myelin sheath or retinal ganglion cells and their axons, resulting in loss of nerve fibers and gliosis. It is a common term in pathology. It usually occurs in the axonal degeneration of ganglion cells between the retina and the lateral geniculate body. Due to the degeneration and atrophy of nerve fibers, patients often have decreased visual function and reduced visual field.
-
Site of disease:
Eye -
Infectious :
Not contagious -
Frequent population:
All groups -
Related symptoms:
Vision is often foggy and blurry Visual impairment Paranasal sinus hypoplasia Visual impairment Narrowed visual field -
Concurrent disease:
Related Drugs
Inosine injection
Indication: It is clinically used for leukopenia or thrombocytopenia, various acute and chronic liver diseases, heart diseases such as cor pulmonale, central retinitis, optic atrophy and other diseases.
Inosine injection
Indication: It is clinically used for leukopenia or thrombocytopenia, various acute and chronic liver diseases, heart diseases such as cor pulmonale, central retinitis, optic atrophy and other diseases.
Manufacturer:
Hubei Qianjiang Pharmaceutical Co., Ltd.
Inosine injection
Indication: It is clinically used for leukopenia or thrombocytopenia, various acute and chronic liver diseases, heart diseases such as cor pulmonale, central retinitis, optic atrophy and other diseases.
Manufacturer:
Hubei Tiansheng Pharmaceutical Co., Ltd.
Inosine injection
Indication: It is clinically used for leukopenia or thrombocytopenia, various acute and chronic liver diseases, heart diseases such as cor pulmonale, central retinitis, optic atrophy and other diseases.
Manufacturer:
Hubei Zhongjia Pharmaceutical Co., Ltd.
Inosine injection
Indication: It is clinically used for leukopenia or thrombocytopenia, various acute and chronic liver diseases, heart diseases such as cor pulmonale, central retinitis, optic atrophy and other diseases.
Manufacturer:
Hubei Kelun Pharmaceutical Co., Ltd.
Inosine injection
Indication: It is clinically used for leukopenia or thrombocytopenia, various acute and chronic liver diseases, heart diseases such as cor pulmonale, central retinitis, optic atrophy and other diseases.
Manufacturer:
Hubei Weishi BIO-PHARMACEUTICAL Co., Ltd.
Inosine injection
Indication: It is clinically used for leukopenia or thrombocytopenia, various acute and chronic liver diseases, heart diseases such as cor pulmonale, central retinitis, optic atrophy and other diseases.
Manufacturer:
HUAZHONG Pharmaceutical Co., Ltd.
Inosine injection
Indication: It is clinically used for leukopenia or thrombocytopenia, various acute and chronic liver diseases, heart diseases such as cor pulmonale, central retinitis, optic atrophy and other diseases.
Manufacturer:
Hunan Dongting Pharmaceutical Co., Ltd.
Inosine injection
Indication: It is clinically used for leukopenia or thrombocytopenia, various acute and chronic liver diseases, heart diseases such as cor pulmonale, central retinitis, optic atrophy and other diseases.
Manufacturer:
Yueyang Hudex Pharmaceuticals Ltd.
Inosine injection
Indication: It is clinically used for leukopenia or thrombocytopenia, various acute and chronic liver diseases, heart diseases such as cor pulmonale, central retinitis, optic atrophy and other diseases.
Manufacturer:
Hunan Wzt Pharmaceutical Co., Ltd.